![Tilmann M. Brotz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tilmann M.
Brotz worked as a Director of Preclinical Development at Renovis, Inc. and as a Vice President of Preclinical Development at VIA Pharmaceuticals, Inc. He holds a doctorate degree from Eberhard Karls Universität Tübingen.
| Sociétés | Poste | Fin |
|---|---|---|
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
| VIA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VIA Pharmaceuticals, Inc.
 VIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for the treatment of cardiovascular and metabolic disease | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
